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1. Introduction
   Epilepsy, which has been described as a chronic 
disorder of the central nervous system of various etiologies, 
characterized by recurrent seizures due to excessive 
discharge of cerebral neurons is a major medical and social 
problem[1]. The incidence of the disease in developing 
countries is higher than that in developed countries and 
is reported to be 190 per one lakh people. There are many 
classes of anticonvulsants that are of clinical usefulness 
with good prognosis for controlling seizures in most 
patients. The currently available anticonvulsant drugs suffer 
from drawbacks like neurotoxicity, teratogenic and other 
dose related side effects[2]. In order to reduce the risk of 
side effects, overcome resistance and achieve safety and 
effectiveness, the use of anticonvulsant drugs combination 
is a fundamental strategy in assessment of epilepsy[3]. 
In the last years a number of herbal products have been 
demonstrated to have promising anticonvulsant activity[4]. 
These herbal products are candidates to be included in 
combination therapy of epilepsy due to their considerable 
safety and lower side effects. Mussaenda philippica
(M. philippica) (Aurorae) of family Rubiaceae is distributed 
in throughout India, South East Asia. The flowers are small, 
tubelike, expanded into five, ovate lobes, yellowish orange 
in colour. In traditionally the plant is used as dysentery, 
jaundice, emollient and snake bites. Thus, it is necessary 
to investigate for an antiepileptic agent that is highly 
efficacious as well as safe in items of drug related toxicity. 
The aim of treating an epileptic is not only to abolish 
the occurrence of seizures. Hence the objective of this 
study was to investigate the effect of different extracts of
M. philippica on the anticonvulsant activity. 
2. Materials and methods
2.1. Plant material
   Fresh leaves and sepals of the M. philippica (Aurorae) 
collected from commercial nurseries of Bhubaneswar, 
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Khurda district, Odisha, during the month of July and 
August 2011 in the early morning. The plant was identified, 
confirmed and authenticated by taxonomist Prof. Sushil 
Kumar Mallick in the Department of Botany, S.V.M 
Autonomous College, Bhubaneswar.
2.2. Animals
   Swiss albino mice (20-25 g) and Wistar albino rats (150-
180 g) of either sex were used in the study. Animals were 
procured from SPS, SOAU, BBSR (RegdNo. 1171/C/08/
CPCSEA). The animals were acclimatized in the laboratory 
conditions for 7 d before experimentation. The animals had 
free access to food and water ad libitum and maintained 
under 12 h day and night cycles. All experiments were 
carried out during day time from 9.00 am to 14.00 pm.
2.3. Preparation of extracts and fractions
   The air dried plant materials was powdered and extracted 
successively with the different solvents. First the powered 
was extracted with petroleum ether in a soxhlet apparatus. 
The extraction was continued till the defatting of the 
material had taken place. The defatted marc of the drug 
was subjected to hydroalcoholic extraction for a period 
of 6-7 d and filtered. All the filtrates were subjected to 
evaporation by using Rotary Evaporator to dryness, till the 
thick paste remained in the evaporator. However, it was kept 
in a refrigerator below 4 曟 till the experimental study. The 
extract obtained was fractionated by using ethyl-acetate, 1, 
4-dioxane, methanol & ethanol in the order of increasing 
polarity. Extract was subjected to qualitative chemical 
investigation of phytoconstituents such as Alkaloids, 
Flavonoids, Ttannins, Carbohydrates, Proteins, Vitamins, 
Coumarin etc by using  different methods[5,6].
2.4. Toxicity tests
   Nine groups with each group containing five mice and five 
rats were used for each of the three extracts. Groups 1-8 
were injected intraperitoneally with 25, 50, 100, 200, 400, 
800, 1 600, and 2 000 mg/kg, while the ninth group received 
10 mL/kg normal saline. Mortality rate was observed and 
recorded for 24 h period[7].
2.5. Anticonvulsant activity
   The anticonvulsant effect of extracts was studied by the 
Maximal electroshock (MES),  Picrotoxin, Pentylenetetrazole 
(PTZ) and Strychnine-induced seizures.
2.6. Maximal electroshock (MES) induced convulsion
   Protection against electroshock induced seizures in mice 
or rats is used as an indication for compounds which may 
prove effective in ‘grand mal epilepsy’. Electric stimuli 
evoke tonic hind limb extensions, which are suppressed 
by anti-epileptic drugs. The animals were given maximal 
electroshocks of 150 mA for 0.2 s to the cornea by using 
electroconvulsometer[8,9]. Fifty healthy and convulsion free 
Swiss albino rats (120-150 g) were randomly divided into 10 
groups (n=5). The plant aqueous extract and it’s fractions 
at the dose of 100 and 200 mg/kg, standard drug phenytoin 
and vehicle control were administered 30 min prior to 
MES. The vehicle treated animals exhibit the characteristic 
maximal electroshock convulsions which can be divided 
into 5 phases- (a) tonic flexion, (b) tonic extensor, (c) clonic 
convulsions, (d) stupor and (e) recovery or death. The animals 
are observed for 2 min after the shock. Disappearance of 
the hind limb extensor tonic convulsions is taken as the 
criterion of protection[10].
2.7. Pentylenetetrazole (PTZ)-induced seizure
   This test is considered as indicative of anticonvulsant 
activity of drugs against ‘petit mal seizures’. PTZ produces 
generalized asynchronized clonic movements which are 
superceded by tonic convulsion characterized by flexion 
of limbs followed by extension. The excitatory effects of 
PTZ may be due to decrease in neuronal recovery time in 
the postsynaptic pathway of the spinal cord[11,12]. The plant 
aqueous extract and it’s fractions at the dose of 100 and 200 
mg/kg, standard drug phenobarbitone sodium and vehicle 
control were administered 30 min prior to PTZ (80 mg/kg). 
The onset and number of death after showing tonic hindlimb 
extension were also recorded. Mice that did not convulse 30 
min after pentylenetetrazole administration were considered 
protected[13]. 
2.8. Picrotoxin-induced seizure
   Picrotoxin is a GABA-antagonist and it modifies the 
function of the Cl- ion channel of the GABA receptor 
complex. Activation of GABA receptor effects inhibition 
of the post-synaptic cell by increasing the flow of Cl- ions 
into the cells, which tends to hyperpolarize the neurons. 
The plant aqueous extract (AEMP) and it’s fractions at the 
dose of 100 and 200 mg/kg, standard drug phenobarbitone 
sodium and vehicle control were administered 30 min prior 
to Picrotoxin (6 mg/kg). Time for onset of action (clonic 
and tonic seizures) and death were the two parameters 
used to evaluate antiepileptic activity of the drugs. Delay 
in onset of action and death of animals was considered as 
anticonvulsant property[14,15].
2.9. Strychnine (STR) induced seizure
   Strychnine is a powerful convulsant. The convulsant 
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action of strychnine is due to interference with post-
synaptic inhibition that is mediated by glycine. Glycine 
is an important inhibitory transmitter to motorneurons 
and interneurons in the spinal cord. The test drug at the 
doses of 100 and 200 mg/kg, standard drug phenobarbitone 
sodium and vehicle control were administered 30 min prior 
to Strychnine (2.5 mg/kg). Sixty healthy and convulsion free 
Swiss albino mice (20-25 g) were randomly divided into 
10 groups (n=6). Then the treatment was started in similar 
manner as described above. Onset to forelimb clonic and 
tonic seizures was recorded. Mice that did not convulse 
30 min after strychnine administration were considered 
protected[16,17]. 
2.10. Statistical analysis
   Results are presented as mean依S.E.M. Statistical 
significance between the groups was analyzed by means 
of an analysis of variance followed by Dunnett’s multiple 
comparison tests. P values less than 0.05 were considered 
significant.
3. Results
   Many plants have been used for the treatment of various 
CNS disorders in Indian system of medicine and in other 
ancient systems of the world, out of these only a few have 
been evaluated as per modern system of medicine. From 
many such plants only extracts have been prepared and 
their usefulness evaluated in experimental animals.
3.1. Acute toxicity study
   An acute toxicity study of ALETD was determined in 
mice, as per OECD guidelines No. 423. The extract was 
administered orally to different groups of mice at different 
dose levels and extract produced no mortality up to 2 000 
mg/kg. So 1/5th, 1/10th, and 1/20th of LD50 doses were 
selected for the present study.
3.2. MES induced convulsion
   The result of MES induced convulsion depicted in Table 1. 
The duration of extensor phase was recorded in control and 
drug treated animals before the electroshock. A significant 
(P<0.001) reduction in the extensor phase and a significant 
reduction in stupor phase was observed with Phenytoin 
when compared with control. In the test, the MF, AF with 
AEMP at the dose of 100 mg/kg significantly (P<0.05) failure 
in extensor phase, where as the MF, AF with AEMP at the 
high dose of 200 mg/kg more significantly (P<0.01) failure 
in extensor phase when compared with the solvent control 
group and the result is comparable to that produced by 
phenytoin. In case of stupor phase, similarly the MF, AF with 
AEMP at the dose of 100 mg/kg 99% significantly (P<0.01) 
decrease, where as the MF, AF with AEMP at the high dose 
of 200 mg/kg more significantly (P<0.001) decrease when 
compared to the solvent control group. There was no death 
observed for all the fractions and the test drug.
Table 2. 
Effect of fractions and extracts of M. philippica on Pentylenetetrazole (PTZ)-induced 
seizure in mice.
Group Treatment Dose (mg/kg)
Onset of convulsion 
in minute
Duration of convulsion in 
minute
Gr I NS + Tween 10 mL/kg 1.79依0.05  2.01依0.07
Gr II Phenobarbitone   40  5.54依0.19c 10.43依0.30c
Gr III MF 100 2.10依0.09   2.83依0.24a
Gr IV 200  2.68依0.16a   3.35依0.18a
Gr V DF 100 2.08依0.10  1.92依0.08
Gr VI 200 2.12依0.25  2.09依0.09
Gr VII AF 100 2.04依0.12   3.17依0.13a
Gr VIII 200  2.89依0.15a   3.52依0.17a
Gr IX AEMP 100 1.88依0.21   3.18依0.15a
Gr X 200  2.91依0.26a   3.47依0.17a
Values are expressed in MEAN依S.E.M of six animals. One Way ANOVA followed by 
Dunnet’s t-test. (F-value denotes statistical significance at *P<0.05, **P<0.01) (t-value 
denotes statistical significance at aP<0.05, bP<0.01 and cP<0.001 respectively, in 
comparison to group-I).
3.3. PTZ induced convulsion
   The result of PTZ induced convulsion depicted in Table 
2, the test extract and all the fractions with standard drug 
Table 1. 
Effect of fractions and extracts of M. philippica on MES induced convulsion in rats.
Group Treatment Dose (mg/kg) Time in various phases of convulsion (s)
Flexion Extensor Clonus Stupor R/D
 I NS+Tween 10 mL/kg 4.53依0.26 10.95依0.31 4.55依0.32  181.00依13.75 R
II Phenytoin   25  3.81依0.20a    2.80依0.33c 4.81依0.30   79.31依3.88c R
 III MF 100 4.26依0.17    9.80依0.17a 4.31依0.16 154.33依5.84a R
 IV 200  3.76依0.18a    8.47依0.21b  3.89依0.22a 114.26依5.75c R
 V DF 100 4.07依0.07 10.25依0.21 4.24依0.15 151.83依6.22a R
 VI 200 4.33依0.18 10.14依0.21 4.32依0.18 152.66依6.89a R
 VII AF 100 4.22依0.16    9.92依0.16a 4.28依0.21 153.65依4.62a R
 VIII 200  3.48依0.21b    8.24依0.21b  3.78依0.27a 108.96依3.43c R
 IX AEMP 100  3.89依0.24a    9.06依0.12a 4.30依0.18 150.16依4.60a R
 X 200  3.51依0.18b    8.12依0.15b 3.91依0.29 111.08依5.18c R
Values are expressed in MEAN依S.E.M of six animals. One Way ANOVA followed by Dunnet’s t-test. (F-value denotes statistical significance 
at *P<0.05, **P<0.01) (t-value denotes statistical significance at aP<0.05, bP<0.01 and cP<0.001 respectively, in comparison to group-I).
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delayed the onset of time and increased the duration of 
convulsion except DF at the dose of 100 mg/kg. The MF, AF 
with AEMP at the dose of 200 mg/kg significantly (P<0.05) 
delayed the onset of convulsion and the MF, AF with AEMP 
at the both dose of 100 and 200 mg/kg 95% significantly 
(P<0.05) increased the duration of convulsion except DF 
against PTZ induced convulsion when compared to the 
solvent control group in (1.79依0.05) (onset of convulsion) and 
(2.01依0.07) (duration of convulsion), effect also comparable 
with those result produced by standard drug.
3.4. Picrotoxin-induced seizure
   The result of Picrotoxin induced convulsion depicted in 
Table 3, showed the fractions and the extract delayed the 
onset of time and the duration of convulsion except DF in 
comparison to solvent control, the effect also comparable 
with phenobarbitone. The MF, AF with AEMP at the dose 
level of 100 mg/kg significantly (P<0.05) delayed the onset of 
time whereas the high dose of 200 mg/kg more significantly 
(P<0.01) delayed the onset of time against Picrotoxin induced 
convulsion respectively, when compared with control group. 
Similarly in case of the time of death, the MF, AF with AEMP 
at the dose level of 100 mg/kg significantly (P<0.05) delayed 
and at high dose of 200 mg/kg more significantly delayed 
except DF. The fractions and the extract dose dependently 
and significantly delayed the onset of time and the time of 
death except DF.
Table 3.
Effect of fractions and extract of M. philippica on Picrotoxin-induced seizure in rats.
Group Treatment Dose (mg/kg)
Onset of convulsion 
(sec)
Time of death(sec)
Gr I NS + Tween 10 mL/kg   130.49依1.77 1 256.50依40.93
Gr II Phenobarbitone   10 1 794.90依7.78c   Recovery
Gr III MF 100    156.62依6.34a  1 353.03依40.61a
Gr IV 200    214.98依8.81b  1 496.28依67.31b
Gr V DF 100   134.02依3.09 1 081.59依52.14
Gr VI 200   133.83依3.56 1 147.64依50.16
Gr VII AF 100    163.69依3.76a 1 357.79依36.51a
Gr VIII 200      222.23依12.73b 1 497.87依48.87b
Gr IX AEMP 100   156.97依5.51a 1 337.18依51.26a
Gr X 200    208.92依6.12b 1 602.13依53.34b
Values are expressed in MEAN依S.E.M of six animals. One Way ANOVA followed by 
Dunnet’s t-test. (F-value denotes statistical significance at *P<0.05, **P<0.01) (t-value 
denotes statistical significance at aP<0.05, bP<0.01 and cP<0.001 respectively, in 
comparison to group-I).
3.5. Strychnine induced convulsion
   The result of Strychnine induced convulsion depicted in 
Table 4, showed the fractions and the extract delayed the 
onset of convulsion and the duration of convulsion except 
DF. Phenobarbitone in a dose of 40 mg/kg; i.p, 99.99% 
significantly delayed the onset of convulsion and duration 
of convulsion respectively, when compared with control 
group. The MF, AF with AEMP at the dose level of 100 mg/kg 
significantly (P<0.01) delayed the onset of time and while 
at the high dose of 200 mg/kg more significantly (P<0.001) 
delayed the onset of time against strychnine induced 
convulsion. Similarly in case of the duration of convulsion, 
the MF, AF with AEMP at the dose level of 100 mg/kg 
significantly (P<0.05) delayed and at high dose of 200 mg/kg 
more significantly delayed. The DF at the dose level of 200 
mg/kg significantly (P<0.05) delayed the onset of time with 
duration of convulsion. The fractions and the extract dose 
ependently and significantly delayed the onset of time and 
the duration of convulsion except DF.
Table 4. 
Effect of fractions and extracts of M. philippica on Strychnine induced seizure in mice.
Group Treatment Dose (mg/kg)
Onset of convulsion 
in minute
Duration of convulsion in 
minute
I NS + Tween 10 mL/kg 3.28依0.14 1.78依0.13
II Phenobarbitone   40  9.23依0.16c  7.90依0.18c
III MF 100  5.66依0.18b  2.95依0.09a
IV 200  7.06依0.16c  4.45依0.18b
V DF 100 3.13依0.11 2.32依0.14
VI 200  4.01依0.13a  3.01依0.16a
VII AF 100  5.96依0.10b  3.10依0.08a
VIII 200  7.21依0.14c  4.70依0.17b
IX AEMP 100  4.40依0.12b  3.09依0.13a
X 200  6.96依0.14c  4.56依0.16b
Values are expressed in MEAN依S.E.M of six animals. One Way ANOVA followed by 
Dunnet’s t-test. (F-value denotes statistical significance at *P<0.05, **P<0.01) (t-value 
denotes statistical significance at aP<0.05, bP<0.01 and cP<0.001 respectively, in 
comparison to group-I).
   Preliminary phytochemical analysis performed showed that 
Carbohydrates were not found to be present in the aqueous 
extract AEMP as well as in all the fractions, while flavonoids, 
glycosides, tannins, phenols, reducing sugar, terpenoids 
and saponins were detected in the aqueous extract and in 
all the fractions. In addition to DF, AF with AEMP, alkaloids 
also present in the DF, AF with AEMP while the MF was not 
contained. In MES induced convulsion, the MF, AF with 
AEMP at the dose of 100 mg/kg significantly (P<0.05) failure 
in extensor phase, where as the MF, AF with AEMP at the 
high dose of 200 mg/kg more significantly (P<0.01) failure 
in extensor phase when compared with the solvent control 
group and the result is comparable to that produced by 
phenytoin. The effectiveness of the extract and the MF, AF 
of M. philippica in the experimental convulsion paradigm 
used probably suggests that the herb could be used in both 
the petitmal and grand mal types of epilepsy. In study of 
Picrotoxin-induced convulsion, the MF, AF and the extract 
AEMP significantly (P<0.05 to P<0.01) and dose dependent 
manner increase in onset of convulsion while a significant 
(P<0.05 to P<0.01) and dose dependant delay in the time of 
death. Similarly in study of Strychnine induced convulsion, 
the MF, AF and the extract AEMP significantly (P<0.05 to 
P<0.01) and dose dependently manner increase in onset of 
convulsion while a significant (P<0.05 to P<0.01) and dose 
dependant increase in the time of death and in the PTZ 
induced convulsion, the MF, AF and the extract AEMP at the 
dose level of 200 mg/kg significantly (P<0.05) increased the 
onset of convulsion while a significant (P<0.05) increase in 
the duration of convulsion. Picrotoxin (PCT), Strychnine (STC) 
and Pentylenetetrazole (PTZ) are convulsants drugs used 
to induce convulsions, while ability of an agent to inhibit 
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convulsion in comparison with the untreated mice. The test 
fractions (MF and AF) and the extract AEMP appears to be 
relatively more effective in Picrotoxin- and Strychnine-
induced convulsions. Picrotoxin (PCT) and strychnine (STC) 
produce their convulsions by blocking gamma-aminobutyric 
acid (GABA) and glycine receptors respectively, while 
pentyltetrazole (PTZ) destabilizes nervous cell membrane to 
produce convulsion[18]. GABA is the predominant inhibitory 
neurotransmitter in the mammalian CNS, and is widely 
implicated in epilepsy, mediating inhibition of neuronal 
responsiveness (excitability) and activity by increasing the 
chloride ion conductance through opening of the chloride-
ion channel[19]. The findings of the present study, therefore, 
tend to suggest that the M. philippica extract & fractions 
might have inhibited and/or attenuated PTZ-induced 
seizures by enhancing, or in some ways interfering with 
GABAergic neurotransmission & also protection of mice 
against Strychnine induced seizure. Strychnine blocked 
glycine mediated neuronal activities in the spinal cord 
thereby inducing a tonic type of convulsion in animal. The 
fact that the MF, AF with the extract AEMP was capable of 
offering protection against different types of seizure models 
indicate that the fractions (MF & DF) and the extract AEMP 
must be acting through different mechanisms to elicit its 
anticonvulsant effects.
4. Conclusion
   It was concluded that the hydroalcoholic extract of 
M. philippica in small to moderate doses (100-200 mg/
kg) enhances the anticonvulsant effects in different 
animal models. This effect may be attributed to different 
mechanisms including the brain glutamate and increasing 
brain GABA levels, inhibition of free radical generation, 
scavengering of reactive oxygen species and reactivation of 
antioxidant defenses. Results of this study direct the light 
towards the possible use of conventional anticonvulsant and 
M. philippica exatracts combination in treatment of epilepsy 
in human.
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